Iron Deficiency in Long-Term Parenteral Nutrition Therapy

Journal of Parenteral and Enteral Nutrition

Volumn 40, Issue 6, 2016, Pages 869-876

  Hwa, Yi L ^a   Rashtak, Shahrooz ^a   Kelly, Darlene G ^a   Murray, Joseph A ^a  

^a MAYO CLINIC   (United States)

Author keywords

dysmotility; fistulae; home parenteral nutrition; intravenous iron replacement; iron deficiency anemia; short bowel syndrome; small bowel obstruction

Indexed keywords

FERRITIN; FERROUS GLUCONATE; HEMOGLOBIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IRON DEXTRAN; IRON SACCHARATE; PROTON PUMP INHIBITOR; IRON;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; BARIATRIC SURGERY; CELIAC DISEASE; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DIET THERAPY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTRIC DYSMOTILITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTESTINE OBSTRUCTION; IRON DEFICIENCY ANEMIA; IRON DEPLETION; IRON STORAGE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; PARENTERAL NUTRITION; PRIORITY JOURNAL; RADIATION ENTEROPATHY; BLOOD; DEFICIENCY; DIETARY SUPPLEMENT; ENTEROPATHY; HOME PARENTERAL NUTRITION; MIDDLE AGED; NUTRITIONAL STATUS; PROCEDURES; TIME FACTOR;

ANEMIA, IRON-DEFICIENCY; DIETARY SUPPLEMENTS; ERYTHROCYTE INDICES; FEMALE; FERRITINS; HEMOGLOBINS; HUMANS; INTESTINAL DISEASES; IRON; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PARENTERAL NUTRITION; PARENTERAL NUTRITION, HOME; TIME FACTORS;

EID: 84978975566     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607115587329     Document Type: Article

References (40)

1. Siepler J,. Principles and strategies for monitoring home parenteral nutrition. Nutr Clin Pract. 2007; 22 (3): 340-350.
2. Bozzetti F, Staun M, Van Gossum A, eds. Home Parenteral Nutrition. Cambridge, MA: CAB International; 2006.
3. Khaodhiar L, Keane-Ellison M, Tawa NE, Thibault A, Burke PA, Bistrian BR,. Iron deficiency anemia in patients receiving home total parenteral nutrition. JPEN J Parenter Enteral Nutr. 2002; 26 (2): 114-119.
4. Burns DL, Mascioli EA, Bistrian BR,. Effect of iron-supplemented total parenteral nutrition in patients with iron deficiency anemia. Nutrition. 1996; 12 (6): 411-415.
5. Porter KA, Blackburn GL, Bistrian BR,. Safety of iron dextran in total parenteral nutrition: a case report. J Am Coll Nutr. 1988; 7 (2): 107-110.
6. Auerbach M, Witt D, Toler W, Fierstein M, Lerner RG, Ballard H,. Clinical use of the total dose intravenous infusion of iron dextran. J Lab Clin Med. 1988; 111 (5): 566-570.
7. Kumpf VJ, Holland EG,. Parenteral iron dextran therapy. DICP. 1990; 24 (2): 162-166.
8. Fletes R, Lazarus JM, Gage J, Chertow GM,. Suspected iron dextran-related adverse drug events in hemodialysis patients. Am J Kidney Dis. 2001; 37 (4): 743-749.
9. Vaughan LM, Small C, Plunkett V,. Incompatibility of iron dextran and a total nutrient admixture. Am J Hosp Pharm. 1990; 47 (8): 1745-1746.
10. Kinney R,. 2005 annual report: ESRD clinical performance measures project. Am J Kidney Dis. 2006; 48 (4)(suppl 2): S1-S106.
11. Kshirsagar AV, Freburger JK, Ellis AR, Wang L, Winkelmayer WC, Brookhart MA,. The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med. 2013; 126 (6): 541.e1-541.e14.
12. Robinson CA, Sawyer JE,. Y-site compatibility of medications with parenteral nutrition. J Pediatr Pharmacol Ther. 2009; 14 (1): 48-56.
13. Khaodhiar L, Keane-Ellison M, Tawa NE, Thibault A, Burke PA, Bistrian BR,. Iron deficiency anemia in patients receiving home total parenteral nutrition. JPEN J Parenter Enteral Nutr. 2002; 26 (2): 6.
14. Kumpf VJ,. Parenteral iron supplementation. Nutr Clin Pract. 1996; 11 (4): 139-146.
15. Forbes A,. Iron and parenteral nutrition. Gastroenterology. 2009; 137 (suppl 1): 8.
16. Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG,. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem. 1998; 44 (1): 45-51.
17. Clark SF,. Iron deficiency anemia: diagnosis and management. Curr Opin Gastroenterol. 2009; 25 (2): 122-128.
18. Chang J, Bird R, Clague A, Carter A,. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients. Pathology. 2007; 39 (3): 349-353.
19. World Health Organization. Iron Deficiency Anemia: Assessment, Prevention and Control. Geneva, Switzerland: World Health Organization; 2001.
20. Evstatiev R, Marteau P, Iqbal T, et al. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology. 2011; 141 (3): 846-853, e841-e842.
21. Beutler EFV,. Iron Deficiency. New York, NY: McGraw-Hill; 2001.
22. Vaucher P, Druais PL, Waldvogel S, Favrat B,. Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. CMAJ. 2012; 184 (11): 1247-1254.
23. Soffer EE,. Small bowel dysmotility. Curr Treat Options Gastroenterol. 1998; 1 (1): 8-14.
24. DiCecco S, Nelson J, Burnes J, Fleming CR,. Nutritional intake of gut failure patients on home parenteral nutrition. JPEN J Parenter Enteral Nutr. 1987; 11 (6): 529-532.
25. Waldo RT,. Iron-deficiency anemia due to silent celiac sprue. Proc (Bayl Univ Med Cent). 2002; 15 (1): 16-17.
26. Gesquiere I, Lannoo M, Augustijns P, Matthys C, Van der Schueren B, Foulon V,. Iron deficiency after Roux-en-Y gastric bypass: insufficient iron absorption from oral iron supplements. Obes Surg. 2014; 24 (1): 56-61.
27. Yetman AT, Everitt MD,. The role of iron deficiency in protein-losing enteropathy following the Fontan procedure. Congenit Heart Dis. 2011; 6 (4): 370-373.
28. Qunibi WY,. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review. Arzneimittelforschung. 2010; 60 (6a): 399-412.
29. Auerbach M, Ballard H,. Intravenous iron in oncology. J Natl Compr Canc Netw. 2008; 6 (6): 585-592.
30. Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007; 13 (12): 1545-1553.
31. Qunibi WY, Martinez C, Smith M, Benjamin J, Mangione A, Roger SD,. A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients. Nephrol Dial Transplant. 2011; 26 (5): 1599-1607.
32. Varma S, Baz W, Badine E, et al. Need for parenteral iron therapy after bariatric surgery. Surg Obes Relat Dis. 2008; 4 (6): 715-719.
33. Driscoll DF,. Clinical issues regarding the use of total nutrient admixtures. DICP. 1990; 24 (3): 296-303.
34. Norton JA, Peters ML, Wesley R, Maher MM, Brennan MF,. Iron supplementation of total parenteral nutrition: a prospective study. JPEN J Parenter Enteral Nutr. 1983; 7 (5): 457-461.
35. Koutroubakis IE, Oustamanolakis P, Karakoidas C, Mantzaris GJ, Kouroumalis EA,. Safety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease. Dig Dis Sci. 2010; 55 (8): 2327-2331.
36. Food and Drug Administration. Dexferrum (Iron Dextran Injection): Labeling Change. Washington, DC: Food and Drug Administration; 2009.
37. Power-Burns M,. Adult multi-trace element availability. http://www.fda.gov/downloads/drugsafety/drugshortages/ucm355392.pdf. Published 29, 2013.
38. Bothwell TH,. Overview and mechanisms of iron regulation. Nutr Rev. 1995; 53 (9): 237-245.
39. Kumpf VJ,. Update on parenteral iron therapy. Nutr Clin Pract. 2003; 18 (4): 318-326.
40. Ben Hariz M, Goulet O, De Potter S, et al. Iron overload in children receiving prolonged parenteral nutrition. J Pediatr. 1993; 123 (2): 238-241.